Luke R. Bonser

1.8k total citations
15 papers, 939 citations indexed

About

Luke R. Bonser is a scholar working on Physiology, Immunology and Molecular Biology. According to data from OpenAlex, Luke R. Bonser has authored 15 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 9 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Luke R. Bonser's work include Asthma and respiratory diseases (9 papers), IL-33, ST2, and ILC Pathways (6 papers) and Respiratory viral infections research (3 papers). Luke R. Bonser is often cited by papers focused on Asthma and respiratory diseases (9 papers), IL-33, ST2, and ILC Pathways (6 papers) and Respiratory viral infections research (3 papers). Luke R. Bonser collaborates with scholars based in United States, Japan and China. Luke R. Bonser's co-authors include David J. Erle, Lorna Zlock, Walter E. Finkbeiner, Prescott G. Woodruff, Dan Cheng, Kyung Duk Koh, Huimin Shi, Guohua Zhen, Jianping Zhao and Lingling Yi and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Luke R. Bonser

15 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke R. Bonser United States 13 485 381 339 199 105 15 939
Mahesh Raundhal United States 12 606 1.2× 262 0.7× 545 1.6× 206 1.0× 132 1.3× 15 1.0k
Yaniv Tomer United States 20 308 0.6× 767 2.0× 236 0.7× 267 1.3× 128 1.2× 41 1.2k
Zhixuan Loh Australia 16 279 0.6× 180 0.5× 403 1.2× 156 0.8× 101 1.0× 23 803
Marie Toussaint United Kingdom 10 305 0.6× 180 0.5× 512 1.5× 154 0.8× 85 0.8× 17 791
Michaela Schedel United States 18 607 1.3× 196 0.5× 616 1.8× 247 1.2× 120 1.1× 35 1.1k
Koa Hosoki United States 20 404 0.8× 204 0.5× 284 0.8× 362 1.8× 94 0.9× 50 1.1k
Benoît Allard Canada 15 211 0.4× 272 0.7× 250 0.7× 178 0.9× 44 0.4× 23 712
Rachael Huff United States 7 386 0.8× 136 0.4× 350 1.0× 138 0.7× 80 0.8× 8 608
Anna Maria Merendino Italy 13 549 1.1× 470 1.2× 365 1.1× 437 2.2× 80 0.8× 15 1.2k
Hock L. Tay Australia 18 285 0.6× 178 0.5× 451 1.3× 314 1.6× 91 0.9× 26 972

Countries citing papers authored by Luke R. Bonser

Since Specialization
Citations

This map shows the geographic impact of Luke R. Bonser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke R. Bonser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke R. Bonser more than expected).

Fields of papers citing papers by Luke R. Bonser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke R. Bonser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke R. Bonser. The network helps show where Luke R. Bonser may publish in the future.

Co-authorship network of co-authors of Luke R. Bonser

This figure shows the co-authorship network connecting the top 25 collaborators of Luke R. Bonser. A scholar is included among the top collaborators of Luke R. Bonser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke R. Bonser. Luke R. Bonser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yang, Junjiao, Yinghong Xiao, Peter V. Lidsky, et al.. (2023). Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2. Nature Microbiology. 8(1). 121–134. 12 indexed citations
2.
Bonser, Luke R., Walter L. Eckalbar, Lauren Rodriguez, et al.. (2022). The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium. American Journal of Respiratory Cell and Molecular Biology. 66(4). 391–401. 34 indexed citations
3.
Koh, Kyung Duk, Luke R. Bonser, Walter L. Eckalbar, et al.. (2022). Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma. Cell Genomics. 3(1). 100229–100229. 10 indexed citations
4.
Bonser, Luke R., Walter L. Eckalbar, Lauren Rodriguez, et al.. (2022). The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium.. PubMed. 66(4). 391–401. 25 indexed citations
5.
Siddiqui, Sana, Kristina Johansson, Luke R. Bonser, et al.. (2021). Epithelial miR-141 regulates IL-13–induced airway mucus production. JCI Insight. 6(5). 53 indexed citations
6.
Bonser, Luke R., Kyung Duk Koh, Kristina Johansson, et al.. (2020). Flow-Cytometric Analysis and Purification of Airway Epithelial-Cell Subsets. American Journal of Respiratory Cell and Molecular Biology. 64(3). 308–317. 36 indexed citations
7.
Johansson, Kristina, Salman Siddiqui, Luke R. Bonser, et al.. (2020). Epithelial MicroRNA-141 Regulates IL-13-Induced Airway Mucus Production. A7468–A7468. 1 indexed citations
8.
Koh, Kyung Duk, Sana Siddiqui, Dan Cheng, et al.. (2019). Efficient RNP-directed Human Gene Targeting Reveals SPDEF Is Required for IL-13–induced Mucostasis. American Journal of Respiratory Cell and Molecular Biology. 62(3). 373–381. 26 indexed citations
9.
Bonser, Luke R. & David J. Erle. (2019). The airway epithelium in asthma. Advances in immunology. 142. 1–34. 40 indexed citations
10.
Bhakta, Nirav R., Stephanie A. Christenson, Srilaxmi Nerella, et al.. (2017). IFN-stimulated Gene Expression, Type 2 Inflammation, and Endoplasmic Reticulum Stress in Asthma. American Journal of Respiratory and Critical Care Medicine. 197(3). 313–324. 84 indexed citations
11.
Rousseau, Karine, Luke R. Bonser, Peter Bradding, et al.. (2017). MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma. CHEST Journal. 152(4). 771–779. 66 indexed citations
12.
Bonser, Luke R. & David J. Erle. (2017). Airway Mucus and Asthma: The Role of MUC5AC and MUC5B. Journal of Clinical Medicine. 6(12). 112–112. 239 indexed citations
13.
Bonser, Luke R., Lorna Zlock, Walter E. Finkbeiner, & David J. Erle. (2016). Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. Journal of Clinical Investigation. 126(6). 2367–2371. 147 indexed citations
14.
Bonser, Luke R., Bradley W. Schroeder, Lisa A. Ostrin, et al.. (2015). The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway. American Journal of Respiratory Cell and Molecular Biology. 53(4). 536–543. 19 indexed citations
15.
Cheng, Dan, Zheng Xue, Lingling Yi, et al.. (2014). Epithelial Interleukin-25 Is a Key Mediator in Th2-High, Corticosteroid-Responsive Asthma. American Journal of Respiratory and Critical Care Medicine. 190(6). 639–648. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026